Pro Medicus Limited (PMCUF)
Pro Medicus Statistics
Share Statistics
Pro Medicus has 104.46M shares outstanding. The number of shares has increased by 0.07% in one year.
| Shares Outstanding | 104.46M |
| Shares Change (YoY) | 0.07% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 52.97M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 176.38 and the forward PE ratio is null. Pro Medicus's PEG ratio is 4.87.
| PE Ratio | 176.38 |
| Forward PE | n/a |
| PS Ratio | 90.42 |
| Forward PS | n/a |
| PB Ratio | 77.79 |
| P/FCF Ratio | 193.97 |
| PEG Ratio | 4.87 |
Enterprise Valuation
Pro Medicus has an Enterprise Value (EV) of 14.55B.
| EV / Sales | 90.06 |
| EV / EBITDA | 120.52 |
| EV / EBIT | 177.43 |
| EV / FCF | 193.2 |
Financial Position
The company has a current ratio of 5.98, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.98 |
| Quick Ratio | 5.98 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.03 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 44.1% and Return on Invested Capital is 36.53%.
| Return on Equity | 44.1% |
| Return on Assets | 32.16% |
| Return on Invested Capital | 36.53% |
| Revenue Per Employee | $2.15M |
| Profits Per Employee | $1.1M |
| Employee Count | 75 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 6.14 |
Taxes
| Income Tax | 33.7M |
| Effective Tax Rate | 28.93% |
Stock Price Statistics
The stock price has increased by 63.57% in the last 52 weeks. The beta is 0.48, so Pro Medicus's price volatility has been higher than the market average.
| Beta | 0.48 |
| 52-Week Price Change | 63.57% |
| 50-Day Moving Average | 139.85 |
| 200-Day Moving Average | 132.17 |
| Relative Strength Index (RSI) | 36.87 |
| Average Volume (20 Days) | 591 |
Income Statement
In the last 12 months, Pro Medicus had revenue of 161.5M and earned 82.79M in profits. Earnings per share was 0.79.
| Revenue | 161.5M |
| Gross Profit | 161.2M |
| Operating Income | 114.84M |
| Net Income | 82.79M |
| EBITDA | 120.69M |
| EBIT | 112.18M |
| Earnings Per Share (EPS) | 0.79 |
Balance Sheet
The company has 60.06M in cash and 2.07M in debt, giving a net cash position of 57.99M.
| Cash & Cash Equivalents | 60.06M |
| Total Debt | 2.07M |
| Net Cash | 57.99M |
| Retained Earnings | 173.36M |
| Total Assets | 257.43M |
| Working Capital | 172M |
Cash Flow
In the last 12 months, operating cash flow was 81.98M and capital expenditures -6.69M, giving a free cash flow of 75.29M.
| Operating Cash Flow | 81.98M |
| Capital Expenditures | -6.69M |
| Free Cash Flow | 75.29M |
| FCF Per Share | 0.72 |
Margins
Gross margin is 99.81%, with operating and profit margins of 71.11% and 51.27%.
| Gross Margin | 99.81% |
| Operating Margin | 71.11% |
| Pretax Margin | 72.13% |
| Profit Margin | 51.27% |
| EBITDA Margin | 74.73% |
| EBIT Margin | 71.11% |
| FCF Margin | 46.62% |
Dividends & Yields
PMCUF pays an annual dividend of $0.41, which amounts to a dividend yield of 0.18%.
| Dividend Per Share | $0.41 |
| Dividend Yield | 0.18% |
| Dividend Growth (YoY) | 43.39% |
| Payout Ratio | 67.55% |
| Earnings Yield | 0.57% |
| FCF Yield | 0.52% |
Analyst Forecast
Currently there are no analyst rating for PMCUF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 12, 2019. It was a forward split with a ratio of 1002:1000.
| Last Split Date | Mar 12, 2019 |
| Split Type | forward |
| Split Ratio | 1002:1000 |
Scores
| Altman Z-Score | 112.05 |
| Piotroski F-Score | 7 |